This phase 2 trial tests whether adding isatuximab to standard stem cell transplant procedures can help the immune system better fight multiple myeloma and certain lymphomas. Participants are randomly assigned to receive either standard transplant care alone or isatuximab plus st…
Phase: PHASE2 • Sponsor: Divaya Bhutani • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC